Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
MMP7 Drives EMT-Linked Liver Fibrosis via E-cadherin/β-Caten
2026-06-03
This study elucidates how matrix metalloproteinase 7 (MMP7) accelerates liver fibrosis in biliary atresia by promoting epithelial–mesenchymal transition (EMT) via E-cadherin cleavage and β-catenin signaling activation. The findings highlight MMP7 as a mechanistic and potentially therapeutic target for progressive fibrosis in this pediatric disease.
-
Cefoperazone Sodium Salt: Optimizing Antibacterial Assays
2026-06-03
Cefoperazone sodium salt stands out for its potent, β-lactamase-stable activity against gram-negative bacilli and its pivotal role in resistance modeling. This guide translates benchmark research into actionable protocols, troubleshooting, and advanced use-cases—empowering researchers to achieve high-sensitivity, reproducible data in challenging bacterial infection models.
-
CDK9 Inhibitor (A3294): Technical Use and Workflow Guidance
2026-06-02
CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor designed for research applications requiring targeted transcription elongation inhibition and minimal cytotoxicity. It is not suitable for protocols demanding broad-spectrum CDK inhibition or long-term storage of working solutions.
-
Bufalin: Cardiotonics Driving Advanced Cancer Research Workf
2026-06-02
Bufalin, a cardiotonic steroid from APExBIO, is redefining experimental cancer research by enabling precise molecular degradation and apoptosis induction in triple-negative breast cancer models. Discover optimized workflows, troubleshooting insights, and innovative protocol enhancements for leveraging Bufalin’s unique mechanisms in translational oncology.
-
Alpha-Ketoglutarate in Metabolic Reprogramming: Protocols &
2026-06-01
Alpha-ketoglutarate (α-KGA) is revolutionizing metabolic reprogramming research with its dual roles in mitochondrial metabolism and immune modulation. This article delivers actionable workflows, troubleshooting strategies, and experimental insights drawn from cutting-edge tumor microenvironment studies and the latest protocol innovations.
-
Caspase-3 Fluorometric Assay Kit: Decoding PARP1 Cleavage an
2026-06-01
Explore how the Caspase-3 Fluorometric Assay Kit enables advanced investigation of PARP1 cleavage and ferroptosis-apoptosis crosstalk in cancer biology. This article provides a distinct, mechanism-focused perspective on caspase-3 assay selection and interpretation.
-
Q-VD(OMe)-OPh: Advancing Caspase Inhibition for Translationa
2026-05-31
Explore how Q-VD(OMe)-OPh transforms apoptosis research through precise, low-toxicity pan-caspase inhibition. This article offers a deep analysis of assay design, mechanistic selectivity, and translational impact, with reference to current breakthroughs and practical protocol insights.
-
Amiloride (MK-870): Optimizing Sodium Channel and Endocytosi
2026-05-30
Amiloride (MK-870) is a dual-action inhibitor that enables precise interrogation of epithelial sodium channel and uPAR-mediated signaling in diverse cellular contexts. This guide delivers advanced protocols, troubleshooting insights, and actionable tips to accelerate ion transport and endocytosis research with APExBIO's rigorously benchmarked reagent.
-
Fosinopril Sodium: Optimizing ACE Inhibition in Hypertension
2026-05-29
Fosinopril sodium enables reliable, high-sensitivity ACE inhibition assays with reproducible modulation of blood pressure and renal hemodynamics. Learn how to maximize its potential in cardiovascular disease models with evidence-backed protocol enhancements, troubleshooting insights, and guidance rooted in the latest translational research.
-
HyperPFU™ High-Fidelity DNA Polymerase: Technical Use Guide
2026-05-29
HyperPFU™ high-fidelity DNA polymerase (APExBIO SKU K1031) is designed for accurate PCR amplification of long, GC-rich, or otherwise challenging DNA templates where standard enzymes may fail due to low fidelity or poor processivity. It is best suited for workflows requiring blunt-ended, error-minimized DNA products, but is not appropriate for protocols dependent on 3'-A overhangs or sticky-end ligations.
-
KPT-330 (Selinexor): Optimizing CRM1 Inhibition in Cancer Re
2026-05-28
KPT-330 (Selinexor) stands at the forefront of targeted oncology research, enabling apoptosis induction and tumor growth inhibition through selective CRM1 blockade. This article delivers practical, evidence-driven workflows and troubleshooting strategies to maximize KPT-330’s impact in cancer cell and in vivo models.
-
Probenecid (4-(dipropylsulfamoyl)benzoic acid): Applied Work
2026-05-28
Probenecid is more than a transporter inhibitor: it empowers high-impact workflows in multidrug resistance reversal and neuroprotection models. Explore evidence-backed protocols, troubleshooting strategies, and translational considerations for 4-(dipropylsulfamoyl)benzoic acid from APExBIO.
-
Tofacitinib (CP-690550): Advanced Workflows for Immune Modul
2026-05-27
Tofacitinib (CP-690550) enables precise, multi-modal blockade of inflammatory cytokine signaling and mitochondrial repair in immune cell assays. Its ability to reverse GM-CSF-driven dysfunction in RA macrophages distinguishes it from conventional anti-cytokine or metabolic therapies, making it an indispensable tool for translational immune modulation research.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina
2026-05-27
This study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by inducing ferroptosis through CUL3-mediated ubiquitination of MTDH. The work provides a mechanistic foundation for targeting the CUL3–MTDH axis in ferroptosis-based TNBC therapies and demonstrates the translational potential of gramine in overcoming chemoresistance.
-
Caspase-3 Fluorometric Assay Kit: Illuminating Apoptosis Pat
2026-05-26
Explore the scientific advances in apoptosis quantification enabled by the Caspase-3 Fluorometric Assay Kit. This in-depth review uniquely connects molecular insights from recent hyperthermia-cisplatin research to practical assay decisions, providing researchers with actionable strategies for caspase signaling pathway analysis.